Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-01-01 @ 4:45 AM
Study NCT ID:
NCT07002112
Status:
RECRUITING
Last Update Posted:
2025-08-12
First Post:
2025-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The LVIVO-TaVec100 Product in the Treatment of Relapsed/Refractory B-cell Malignancies
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-23
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-14
First Submit QC Date:
None
Study First Post Date:
2025-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-10
Last Update Post Date:
2025-08-12
Last Update Post Date Type:
ACTUAL